Patent · US Expired

L-glutamic acid derivatives

US4920125A · kind A · utility

19Cited by
1References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 29, 1989
Grant dateApr 24, 1990
Priority date
Expiry dateAug 29, 2009

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Pyrimidin-5-yl derivatives of L-glutamic acid are anti-neoplastic agents. A typical embodiment is N-(4-[5-(2,6-diamino-4-hydroxypyrimidin-5-yl)-butyl]-thien-2-ylcarboxy)-L- glutamic acid.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.